The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking here.
Home Explore Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market 2032: Consumer Shift Toward Safer Alternatives
View in Fullscreen

According to Fortune Business Insights, the global non-steroidal anti-inflammatory drugs (NSAIDs) market was valued at USD 15.58 billion in 2019 and is projected to reach USD 32.33 billion by 2032, exhibiting a CAGR of 5.8% during the forecast period. In 2019, North America dominated the NSAIDs market with a market share of 44.03%.

Like this book? You can publish your book online for free in a few minutes!
Share

Related Publications

Discover the best professional documents and content resources in AnyFlip Document Base.
Search
Published by sachi toshniwal, 2025-07-02 02:05:26

Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market 2032: Consumer Shift Toward Safer Alternatives

According to Fortune Business Insights, the global non-steroidal anti-inflammatory drugs (NSAIDs) market was valued at USD 15.58 billion in 2019 and is projected to reach USD 32.33 billion by 2032, exhibiting a CAGR of 5.8% during the forecast period. In 2019, North America dominated the NSAIDs market with a market share of 44.03%.

Keywords: non-steroidal anti-inflammatory drugs (NSAIDs) market

Click to View FlipBook Version